Edition:
United Kingdom

Allergan PLC Posts Q1 GAAP Loss Per Share $7.25


Tuesday, 7 May 2019 

May 7 (Reuters) - Allergan plc ::ALLERGAN REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 GAAP LOSS PER SHARE $7.25.Q1 EARNINGS PER SHARE ESTIMATE $3.55 -- REFINITIV IBES DATA.Q1 NON-GAAP PERFORMANCE NET INCOME PER SHARE OF $3.79.RAISES FULL-YEAR 2019 GUIDANCE FOR NET REVENUE AND NON-GAAP PERFORMANCE NET INCOME PER SHARE.QTRLY TOTAL NET REVENUE $ 3,597.1 MILLION VERSUS $3,672.1 MILLION REPORTED LAST YEAR.Q1 GAAP NET REVENUE DRIVEN BY GROWTH IN TOP PROMOTED PRODUCTS INCLUDING BOTOX , VRAYLAR , JUVÉDERM COLLECTION OF FILLERS AND LO LOESTRIN.RESTASIS NET REVENUES IN Q1 OF 2019 WERE $231.7 MILLION, A DECREASE OF 9.4 PERCENT VERSUS PRIOR YEAR QUARTER.ALLERGAN RECORDED A GOODWILL IMPAIRMENT OF $2.47 BILLION IN THREE MONTHS ENDED MARCH 31, 2019.SEES FY GAAP REVENUE $15.125 BILLION - $15.425 BILLION.SEES FY NON GAAP REVENUE $15.100 BILLION - $15.400 BILLION.SEES FY GAAP LOSS PER SHARE GREATER THAN $5.70.SEES Q2 TOTAL NET REVENUES $3.875 BILLION - $4.025 BILLION.SEES Q2 NET INCOME PER SHARE $0.50 - $0.70.SEES FY NON GAAP EARNINGS PER SHARE GREATER THAN $16.55.FY2019 EARNINGS PER SHARE VIEW $16.44, REVENUE VIEW $15.20 BILLION -- REFINITIV IBES DATA.Q1 REVENUE VIEW $3.54 BILLION -- REFINITIV IBES DATA.SEES Q2 NON-GAAP NET INCOME PER SHARE $4.20 - $4.40.SEES Q2 NON-GAAP REVENUE $3.850 BILLION- $4.000 BILLION.QTRLY BOTOX NET REVENUE $868.4 MILLION VERSUS $817.3 MILLION.Q2 EARNINGS PER SHARE VIEW $4.20, REVENUE VIEW $3.87 BILLION -- REFINITIV IBES DATA.